HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Tumor recurrence following negative second-look laparotomy in ovarian carcinoma].

Abstract
Between January 1980 and December 1990, 107 ovarian carcinoma patients in clinical complete remission were submitted to a second-look laparotomy at our department. Borderline carcinomas were excluded from the study. Second-look laparotomy was negative in 78.5% of the cases (84 patients). During the follow-up period after the second-look-laparotomy (mean 59 months, range 6 to 120), a recurrence of the tumour was diagnosed in 7 patients (8.4% false-negative rate). This took place after a mean time of 39 months following the previous negative second-look (range 8 to 108). Three of the recurrences were localized in the pelvis, two in the upper abdomen and two in the paraaortic and supraclavicular lymph nodes, respectively. All patients with a recurrence belonged to the group having received adjuvant chemotherapy for one year after initial surgery. At the present time we lack any means to anticipate which patients with a negative second-look will eventually show a recurrence of their tumour.
AuthorsJ Schneider, M Barbazan, M Centeno, F Montoya, J L Neyro, F J Rodriguez-Escudero
JournalZentralblatt fur Gynakologie (Zentralbl Gynakol) Vol. 113 Issue 22 Pg. 1246-50 ( 1991) ISSN: 0044-4197 [Print] Germany
Vernacular TitleAnalyse der Tumorrezidive nach negativer Second-Look-Laparotomie beim Ovarialkarzinom.
PMID1755261 (Publication Type: English Abstract, Journal Article)
Topics
  • Carcinoma (pathology, surgery)
  • False Negative Reactions
  • Female
  • Humans
  • Laparotomy
  • Neoplasm Recurrence, Local
  • Neoplasm Staging
  • Ovarian Neoplasms (pathology, surgery)
  • Reoperation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: